Meridiem Capital Partners LP Guardant Health, Inc. Transaction History
Meridiem Capital Partners LP
- $1.42 Trillion
- Q2 2025
A detailed history of Meridiem Capital Partners LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Meridiem Capital Partners LP holds 50,782 shares of GH stock, worth $4.72 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
50,782Holding current value
$4.72 Million% of portfolio
0.19%Shares
1 transactions
Others Institutions Holding GH
# of Institutions
425Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$1.13 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$1.05 Billion0.01% of portfolio
-
Baillie Gifford & CO5.13MShares$477 Million0.25% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$463 Million0.05% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$395 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $9.51B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...